Phone: (414) 918-9822    Email: [email protected]

CARRA-AF Large Grants

 

CARRA-AF Grant Applications to Include:

  • LOI (due September 1)
  • Abstract (300 word max)
  • 2-3 sentence lay summary of your project.
  • Specific aims (1 page), research plan (3 page limit for publications support, small, and fellows grants; 5 page limit for large grants), and references (no page limit). (Download template: WORD)
  • Budget and justification (Download template: WORD / PDF)
  • NIH-formatted biosketches for PI and all co-Is (5 page limit per biosketch; please combine all biosketches into one PDF with the PI biosketch on top/listed first.)
  • Letters of support
    • Required for budgets that include investigator effort (include letter from division chief documenting that % effort is available, and confirming investigator salary). Total costs salary support must not exceed 50% of total project costs.
    • Letters of support from collaborators, mentors and institution for all other applications are highly recommended.

Click here to view a pdf document of everything you will asked to provide in the online grant application form. 

Use the templates provided when you submit your final application. Once you have read all information below and have your application ready:


Important information for Large Grant Submissions

The next round of CARRA-AF Large Grants will be announced in Summer 2018.

This funding opportunity supports the development and publication of a clinical or translational project which will immediately impact research projects within CARRA or result in a larger collaborative grant that furthers the CARRA mission. New or early investigators are encouraged to apply and will be afforded special consideration.  A successful application may be for:

  • an all-inclusive clinical or translational research project; or
  • a pilot research project, that if successful, could lead to extramural funding.

Preference will be given to submissions which are collaborative and leverage current CARRA network resources or will further develop the CARRA network.

Details:

  • A maximum of 2 grants will be awarded per year.
  • The funding limit of each grant is $50,000 total costs.
  • Salary/Effort: Letters of support are required for budgets that include investigator effort (include letter from division chief documenting that % effort is available, and confirming investigator salary). Total costs salary support must not exceed 50% of total project costs.
  • This is a total costs award. If indirects are requested, they must be inclusive of the maximum funding amount of $50,000. Indirects may not exceed 8%.
  • A given investigator can only receive one grant (large or small) per 365 day period.
  • Funds will be provided to the awardee through a contract between the PI’s institution and CARRA.
  • The project period is one year from the date of award.
  • A project report is required upon completion of the project or end of project period, whichever occurs first.
  • If the PI is unable to complete the project, any unexpended balance will be returned to CARRA.
  • Awardees are expected to submit an abstract and attend the CARRA Annual Meeting.
  • If the PI is unable to complete the project, any unexpended balance will be returned to CARRA.
  • If requested, CARRA generally accepts up to $25K for salary support with a larger amount considered only under special circumstances with adequate justification.
  • After funding decisions are determined, one large grant will be selected by CARRA to be sponsored by funding received from AOII.

Instructions:

  • Submit a one-page LOI on institution letterhead by September 1 via the online grant submission system.  The LOI should be a one-page signed letter which summarizes your ultimate full proposal.  Contents should include the name of your institution and a short description and aims of the project involved.  You should also include how your project fits CARRA’s guidelines and funding interests. The LOI is for informational purposes only, and approval is not needed to proceed with the full application.
  • Use the template documents provided above and submit your completed CARRA Large Grant application by October 2 via the online grant submission system.

Letter of Intent (LOI)

  • LOI’s are required for those submitting Large Grants (only) and are due September 1. The LOI should be a one-page signed letter which summarizes your ultimate full proposal.  Contents should include the name of your institution and a short description and aims of the project involved.  You should also include how your project fits CARRA’s guidelines and funding interests. The LOI is for informational purposes only, and approval is not needed to proceed with the full application.

Eligibility

  • The project PI for all grants must be a CARRA member in good standing:
    • Member is current on membership dues and membership information (location, contact information, and membership status) is up-to-date.
    • Member participates in at least one Research Committee (e.g. JDM, JIA, SVARD, etc.) of CARRA.
    • Member has attended at least one annual CARRA meeting over the last 3 year period.
  • An investigator may only receive one CARRA grant (large or small) per year (365 day period). 
  • PhD and Masters level researchers, nurses and research coordinators are eligible to submit proposals.
  • Priority will be given to new and/or early investigators.
  • All grants must be submitted by or have a pediatric rheumatologist named as a Co-I.
  • Fellows, residents, and CARRA Executive Committee members are not eligible.

Funding and Funding Period

  • Awards are total costs. Up to 8% F&A (indirect) costs are allowed, but costs must be incorporated into the project budget and not exceed the advertised award amount.
  • Publication, presentation, and travel costs should not be requested/included, unless the travel is an essential part of performing the research.
  • Salary support will be limited to a base-salary cap of $200,000 but can include payment of local fringe rates (on top of $200,000 salary cap).
  • Please review CARRA’s statement of direct and indirect support.
  • After funding decisions are determined, one large and two small grants will be selected by CARRA to be sponsored by funding received from AOII.
  • All awards are for one year, with funding to begin January 2, 2018.
  • Applicants will be notified of funding decisions no later than December 22, 2017.
  • If the project is not completed within the project period, the award recipient may request a no-cost extension (NCE) for up to 12 months.  Requests for NCEs will not be accepted prior to December 1, 2018. Recipient must submit a satisfactory plan for completion and an interim progress report between December 1-31, 2018. 

Reporting

  • Awardees must submit a progress report by December 31, 2018.
  • Awardees from the October, 2017 grant cycle who wish to submit grant applications for the October, 2018 deadline will be required to submit progress reports prior to October 1, 2018. Please use this template for progress reports.
  • Timely provision of progress reports is required for future eligibility for CARRA grants.
  • Awardees are expected to submit abstracts to CARRA and present their findings at the CARRA Annual Scientific Meeting.
    • 2018 abstracts are due January 15, 2018 and should include project/study overview.
    • 2019 abstracts to include project/study results.
    • CARRA will handle poster printing and costs.

Publications

  • Awardees are expected to submit a peer-reviewed abstract to a scientific meeting based on the funded project.
  • All awardees of CARRA funding must abide by the procedures outlined in the CARRA Publications Policy when presenting/publishing findings from their projects. This includes submitting all abstracts and manuscripts to the CARRA Publications Committee for approval prior to submission and acknowledging the support of CARRA and the Arthritis Foundation by including the following language: “The authors wish to acknowledge CARRA, and the ongoing Arthritis Foundation financial support of CARRA.” Refer to the current Publications Policy for complete details.